Does targeting ISG15 help with skin inflammatory diseases?
Skin inflammatory diseases often involve complex immune reactions. One specific molecule called ISG15 plays a dual role in these conditions. It can help regulate internal signals, but free ISG15 outside cells can trigger immune cells and make inflammation worse. Because of this, blocking or targeting the ISG15 pathway is being studied as a new way to treat these diseases.
What the research says
While the exact mechanisms are still being mapped, current reviews highlight the potential value of targeting the ISG15 pathway as a new strategy for treating inflammatory diseases 35. However, a unified framework for managing these reactions is still lacking, particularly in pediatric populations where similar paradoxical inflammatory events occur 1.
What to ask your doctor
- Could my skin condition be driven by the ISG15 pathway or interferon signaling?
- Are there any clinical trials testing drugs that target ISG15 for my specific skin disease?
- How might blocking ISG15 affect my current treatment plan for skin inflammation?
- What are the signs of a paradoxical inflammatory reaction if I start a new biologic therapy?
This question is drawn from common patient questions about Dermatology and answered using cited medical research. We do not provide individualized advice.